The pivotal role of MicroRNAs in glucose metabolism in cancer.
|
| Abstract |
Cancer cells are able to undergo aerobic glycolysis and metabolize glucose to lactate instead of oxidative phosphorylation, which is known as Warburg effect. Accumulating evidence has revealed that microRNAs regulate cancer cell metabolism, which manifest a higher rate of glucose metabolism. Various signaling pathways along with glycolytic enzymes are responsible for the emergence of glycolytic dependence. MicroRNAs are a class of non-coding RNAs that are not translated into proteins but regulate target gene expression or in other words function pre-translationally and post-transcriptionally. MicroRNAs have been shown to be involved in various biological processes, including glucose metabolism via targeting major transcription factors, enzymes, oncogenes or tumor suppressors alongside the oncogenic signaling pathways. In this review, we describe the regulatory role of microRNAs of cancer cell glucose metabolism, including in the glucose uptake, glycolysis, tricarboxylic acid cycle and several signaling pathways and further suggest that microRNA-based therapeutics can be used to inhibit the process of glucose metabolism reprogramming in cancer cells and thus suppressing cancer progression.
|
|---|---|
| Authors | Sina Taefehshokr, Nima Taefehshokr, Nima Hemmat, Saba Hajazimian, Alireza Isazadeh, Pourya Dadebighlu, Behzad Baradaran |
| Journal | Pathology, research and practice (Pathol Res Pract) Vol. 217 Pg. 153314 (Jan 2021) ISSN: 1618-0631 [Electronic] Germany |
| PMID | 33341548 (Publication Type: Journal Article, Review) |
| Copyright | Copyright © 2020 Elsevier GmbH. All rights reserved. |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!